After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Verona Pharma Plc ADR is $7.79B. A total of 0.44 million shares were traded on the day, compared to an average of 1.40M shares.
In the most recent transaction, Fisher Andrew sold 80,000 shares of VRNA for 11.53 per share on Jun 16 ’25. After the transaction, the General Counsel now owns 359,999 company shares. In a previous transaction on Jun 11 ’25, Hahn Mark W sold 400,000 shares at 11.40 per share. VRNA shares that Chief Financial Officer owns now total 12,278,992.
Among the insiders who sold shares, ZACCARDELLI DAVID disposed of 400,000 shares on Jun 11 ’25 at a per-share price of $11.40. This resulted in the President and CEO holding 13,190,168 shares of VRNA after the transaction. In another insider transaction, DAVID ZACCARDELLI bought 50,000 shares at $86.78 per share on Jun 11 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VRNA has a high of $99.01 and a low of $15.15.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $2.66, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 5.00.
